<DOC>
	<DOCNO>NCT02822508</DOCNO>
	<brief_summary>The objective study evaluate multiple dos BLI801 Laxative safety efficacy versus placebo adult experience non-idiopathic constipation .</brief_summary>
	<brief_title>A Safety Efficacy Evaluation BLI801 Laxative Adults Experiencing Non-Idiopathic Constipation</brief_title>
	<detailed_description />
	<mesh_term>Constipation</mesh_term>
	<mesh_term>Laxatives</mesh_term>
	<mesh_term>Cathartics</mesh_term>
	<criteria>1 . Male female subject age &gt; 18 &lt; 85 year 2 . Constipated , define follow criterion : Fewer 3 spontaneous defecation per week least one follow symptom previous 4 week : Straining &gt; 25 % defecation Lumpy hard stool &gt; 25 % defecation Sensation incomplete evacuation &gt; 25 % defecation 3 . Receiving stable maintenance opioid regimen . 4 . If female , childbearing potential , use acceptable form birth control 5 . Negative pregnancy test screening ( Visit 1 ) , applicable 6 . In Investigator 's judgment , subject mentally competent provide inform consent participate study 1 . Subjects know suspected ileus , gastrointestinal obstruction , gastric retention , bowel perforation , toxic colitis toxic megacolon 2 . Subjects major surgery within 30 day Visit 1 ; appendectomy cholecystectomy 60 day Visit 1 ; abdominal , pelvic , retroperitoneal surgery 6 month Visit 1 ; bariatric surgery surgery remove segment GI tract time Visit 1 3 . Medical condition associate diarrhea , intermittent loose stool constipation , could confound interpretation result , eg , fecal incontinence irritable bowel syndrome . Subjects irritable bowel syndrome ( IBS ) previously diagnose physician prior initiation constipate therapy meet follow criterion , exclude : 1 . Absence structural biochemical explanation abdominal pain symptom 2 . At least 12 week period 12 month , abdominal discomfort pain least 2 follow 3 feature : i. Relieved defecation , and/or ii . Onset associate change frequency stool , and/or iii . Onset associate change form stool . 4 . Subjects diagnose chronic constipation prior initiation opioid treatment 5 . Subjects take laxative ( exception fiber supplement ) , prokinetic agent antidiarrheal drug refuse discontinue treatment Visit 1 completion Visit 5 6 . Subjects pregnant nursing , intend become pregnant study 7 . Subjects childbearing potential refuse pregnancy test 8 . Subjects allergic BLI801 component 9 . Subjects take nonopioid medication supplement know cause constipation 10 . Subjects active history drug alcohol abuse 11 . Subjects participate investigational clinical , surgical , drug , device study within past 30 day 12 . Subjects , opinion Investigator , include study reason , include inability follow study procedure . 13 . Subjects colonoscopy within 2 week Visit 1 schedule colonoscopy participation study . 14 . Subjects withdraw consent time prior completion Visit 1 procedure</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>84 Years</maximum_age>
	<verification_date>January 2017</verification_date>
</DOC>